Analysts say the move could intensify competition in a market already dominated by blockbuster GLP-1 drugs and reshape how obesity is treated in primary care
The licensed pharmacist and/or licensed physician maintains the responsibility to ensure compliance with Section 503A of the Food, Drug and Cosmetic Act, including the requirement that a compound be dispensed pursuant to a valid prescription, from a licensed prescriber, for an identified individual patient
Teach patients self-care techniques for maintaining eye health, including proper eye hygiene, protection from UV light, and recognition of warning signs requiring immediate medical attention
Tirzepatide is a dual GLP-1/GIP agonist, already FDA- and EMA-approved for type 2 diabetes (Mounjaro) and obesity (Zepbound)
& Damsbo, P
GLP-1 strongly suppresses appetite, slows gastric emptying, and stimulates insulin while suppressing glucagon